Portal de Periódicos da CAPES

The addition of Tirofiban infusion to heparin for intraoperative heparin resistance associated with Marfan Syndrome

2022; Elsevier BV; Linguagem: Inglês

10.5554/22562087.e1035

2422-0248

Maria José Fernandez-Turizo, David Benavides, Augusto Enrique Anaya-Hoyos, Sebastian Portillo-Gómez, Hernán Darío Castro-Arias,

Cardiac Valve Diseases and Treatments

Marfan syndrome classically presents with aortic root aneurysms. Aortic ectasia causes diverse blood flow alterations, influencing the behavior of coagulation factors and platelet activity. Heparin resistance has also been reported associated with Marfan Syndrome in a small number of patients, probably due to antithrombin III (ATIII) deficiency or various mutations. The ascending aorta and the aortic valve are replaced with prosthetic material during Bentall- de Bonno procedures. Resistance to anticoagulation during extracorporeal circulation, represents a significant challenge for both anesthesiologists and the surgical team. Resistance to heparin was observed in a patient with Marfan syndrome undergoing a Bentall procedure. ATIII concentrate was not available, and ACT did not increase despite high doses of heparin. An alternate anticoagulation approach was used successfully.